Title : Biomarker-Oriented Therapy in Bladder and Renal Cancer.

Pub. Date : 2021 Mar 11

PMID : 33799514






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Currently, patients with metastatic UC (mUC) are usually treated with second-line ICI, while cisplatin-ineligible patients with programmed death-ligand 1 (PD-L1) positive tumors can benefit from first-line ICI. Cisplatin CD274 molecule Homo sapiens
2 Currently, patients with metastatic UC (mUC) are usually treated with second-line ICI, while cisplatin-ineligible patients with programmed death-ligand 1 (PD-L1) positive tumors can benefit from first-line ICI. Cisplatin CD274 molecule Homo sapiens